Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.

Vascular health and risk management - 1 Jan 2006

Echols Melvin R, Yancy Clyde W

Abstract excerpt

Despite significant improvement in therapy and management, heart failure remains a worrisome disease state that is especially problematic in special populations. African Americans suffer a disproportionately higher prevalence of heart failure when compared to other populations. It has been recently demonstrated that vasodilator therapy using the combination of isosorbide dinitrate (ISDN) and hydralazine (HYD) as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Black or African American
Share to Drug Combinations
Share to Endothelium, Vascular

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Heart Failure

Share to Nitric Oxide

Share to Oxidative Stress

Share to Patient Selection

Share to Vasodilator Agents

Source

Open in PubMed Open full text

Identifiers

PMID: 17323596
DOI: 10.2147/vhrm.2006.2.4.423
PMCID: PMC1994006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.PMID 17323596Read ↗

Racial differences in heart failure therapeutics.Semantic proximity Read ↗

Heart failure in African Americans.Semantic proximity Read ↗

Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association.Semantic proximity Read ↗

G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT.Semantic proximity Read ↗

Review: Heart failure with preserved ejection fraction in African Americans.Semantic proximity Read ↗

New Management Strategies in Heart Failure.Semantic proximity Read ↗

Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 2): Clinical and Therapeutic Considerations.Semantic proximity Read ↗

Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.Semantic proximity Read ↗

Preclinical Study on the Ameliorating Effect of L-Ascorbic Acid for the Oxidative Stress of Caused by Chronic Administration of Organic Nitrates in Cardiovascular DiseasesSemantic proximity Read ↗

Vascular phenotypes of acute decompensated vs. new-onset heart failure: treatment implications.Semantic proximity Read ↗

Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage.Semantic proximity Read ↗

Hydrogen Sulfide Deficiency and Therapeutic Targeting in Cardiometabolic HFpEF: Evidence for Synergistic Benefit with GLP-1/Glucagon AgonismSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.